Patents by Inventor Myeong Ki JUNG

Myeong Ki JUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210330666
    Abstract: An oral solid formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, and an acidifying agent. A method of preparing an oral solid formulation includes forming granules containing irinotecan or a pharmaceutically acceptable salt thereof, a diluent, and a binder, mixing the granules with a disintegrant and a lubricant to obtain a mixture, and includes adding an acidifying agent in step of forming granules and/or mixing the granules.
    Type: Application
    Filed: July 8, 2021
    Publication date: October 28, 2021
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Caleb Hyung Min PARK, Myeong Ki JUNG, Jin Cheul KIM, Yong Il KIM, Jae Hyun PARK, Jong Soo WOO
  • Patent number: 11090299
    Abstract: An oral solid formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, and an acidifying agent.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: August 17, 2021
    Assignee: HANMI PHARM. CO., LTD.
    Inventors: Caleb Hyung Min Park, Myeong Ki Jung, Jin Cheul Kim, Yong Il Kim, Jae Hyun Park, Jong Soo Woo
  • Publication number: 20180153878
    Abstract: An oral solid formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, and an acidifying agent.
    Type: Application
    Filed: June 20, 2016
    Publication date: June 7, 2018
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Caleb Hyung Min PARK, Myeong Ki JUNG, Jin Cheul KIM, Yong Il KIM, Jae Hyun PARK, Jong Soo WOO